Dual inhibition of CDK12/CDK13 targets both tumor and immune cells in ovarian cancer. Cheng L, Zhou S, Zhou S, Shi K, et al. Cancer Res 2022 Jul 20. pii: 707082. doi: 10.1158/0008-5472.CAN-22-0222.

Read + Share

Amedeo Smart

Independent Medical Education

Cheng L, Zhou S, Zhou S, Shi K, et al. Dual inhibition of CDK12/CDK13 targets both tumor and immune cells in ovarian cancer. Cancer Res 2022 Jul 20. pii: 707082. doi: 10.1158/0008-5472.CAN-22-0222.
PMID: 35857807